{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:07:36Z","timestamp":1788570456914,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.diagmicrobio.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T23:30:09Z","timestamp":1544311809000},"page":"155-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vitro evaluation of antifungal combination against Cryptococcus neoformans"],"prefix":"10.1016","volume":"94","author":[{"given":"Luana","family":"Rossato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erico S.","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarcieli P.","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.S.","family":"Al-Hatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janio M.","family":"Santurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney H.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0005","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/QAI.0b013e31815bad0c","article-title":"The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species","volume":"47","author":"Apisarnthanarak","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.diagmicrobio.2018.12.003_bb2005","series-title":"Approved standard M27-A3","article-title":"Reference method for broth dilution antifungal susceptibility testing of yeast","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0010","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1440-1827.2012.02839.x","article-title":"Coinfection of Aspergillus and Cryptococcus in post-tuberculosis pulmonary cavity","volume":"62","author":"Enoki","year":"2012","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/dki410","article-title":"Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients","volume":"57","author":"Glasmacher","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2018.12.003_bb2010","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","article-title":"Synergistic effect of posaconazole and caspofungin against clinical zygomycetes","volume":"51","author":"Guembe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/viru.18685","article-title":"Molecular mechanisms of cryptococcal meningitis","volume":"3","author":"Liu","year":"2012","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1099\/0022-1317-51-12-1135","article-title":"Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era","volume":"51","author":"Manfredi","year":"2002","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/14787210.4.2.325","article-title":"Echinocandin antifungals: review and update","volume":"4","author":"Morrison","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.14-0452","article-title":"Epidemiology of meningitis in an HIV-infected Ugandan cohort","volume":"92","author":"Rajasingham","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0055","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/mmy\/myv059","article-title":"In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction","volume":"53","author":"Rossato","year":"2015","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0065","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/AAC.49.7.2994-2996.2005","article-title":"In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus","volume":"49","author":"Serena","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2018.12.003_bb0075","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/IAI.00554-13","article-title":"Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells","volume":"81","author":"Vu","year":"2013","journal-title":"Infect Immun"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318307302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318307302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T22:38:46Z","timestamp":1662590326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318307302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0732889318307302"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.12.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of antifungal combination against Cryptococcus neoformans","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}